Ester Caffarel-Salvador

Ester Caffarel-Salvador, PhD, is a skilled professional with extensive experience in strategic innovation, particularly in the realm of rare diseases. Currently serving as the Director of Strategic Innovation at Chiesi USA, Inc., Ester is responsible for scouting innovative therapeutic modalities and designing prioritization strategies to integrate these solutions into the company's R&D model. In addition to this role, Ester contributes to multiple organizations as a Scientific Advisory Board Member and as a Lecturer at the Massachusetts Institute of Technology, where emphasis is placed on science communication and mentoring postdoctoral and graduate students. Previous roles include leadership positions in regenerative medicine and scientific strategy, showcasing a strong background in academia and the pharmaceutical industry, underpinned by a solid educational foundation in biochemistry and pharmacy.